|
TIAM2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.55410000002298E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.67870178763496E-11 |
| Normal-vs-Stage2 |
1.974230E-02 |
| Normal-vs-Stage3 |
5.794900E-04 |
| Normal-vs-Stage4 |
2.551000E-01 |
| Stage1-vs-Stage2 |
1.157810E-01 |
| Stage1-vs-Stage3 |
2.526000E-01 |
| Stage1-vs-Stage4 |
1.132970E-01 |
| Stage2-vs-Stage3 |
5.890000E-01 |
| Stage2-vs-Stage4 |
6.322200E-01 |
| Stage3-vs-Stage4 |
3.597000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.85490000001754E-06 |
| Normal-vs-AfricanAmerican |
1.03169999998709E-06 |
| Normal-vs-Asian |
3.907600E-01 |
| Caucasian-vs-AfricanAmerican |
1.322180E-01 |
| Caucasian-vs-Asian |
5.620400E-01 |
| AfricanAmerican-vs-Asian |
1.273240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.60989999950812E-07 |
| Normal-vs-Female |
1.296160E-03 |
| Male-vs-Female |
2.929600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.58910000000756E-06 |
| Normal-vs-Age(41-60Yrs) |
3.319800E-03 |
| Normal-vs-Age(61-80Yrs) |
5.97579999928044E-08 |
| Normal-vs-Age(81-100Yrs) |
2.01140000000155E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.461600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.877600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.470170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.736400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.057800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.408000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.168200E-04 |
| Normal-vs-Grade 2 |
5.64709945471975E-10 |
| Normal-vs-Grade 3 |
5.197300E-04 |
| Normal-vs-Grade 4 |
5.824200E-02 |
| Grade 1-vs-Grade 2 |
6.136000E-01 |
| Grade 1-vs-Grade 3 |
5.895800E-01 |
| Grade 1-vs-Grade 4 |
2.841000E-01 |
| Grade 2-vs-Grade 3 |
2.117600E-01 |
| Grade 2-vs-Grade 4 |
1.137620E-01 |
| Grade 3-vs-Grade 4 |
5.058600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.35140001808776E-09 |
| Normal-vs-ccB subtype |
2.975200E-04 |
| ccA subtype-vs-ccB subtype |
2.324600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.017500E-04 |
| Normal-vs-N1 |
1.398030E-02 |
| N0-vs-N1 |
6.944000E-01 |
|
|
